Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

  • There is currently no data for JWNG

Director/PDMR Shareholding

3 Sep 2024 07:00

RNS Number : 6121C
Jaywing PLC
03 September 2024
 

3 September 2024

Jaywing plc

("Jaywing" or the "Company")

Director/PDMR Shareholding

 

Jaywing plc ("Jaywing", "the Company") announces that Ian Robinson, Non-Executive Director, has informed the Company that 470,267 ordinary shares in the Company, held by his wife, Patricia Robinson, have been transferred from her investment account into her ISA account, by way of a Bed and ISA transaction.

Following this transaction, Mr Robinson's total beneficial interests remain unchanged at 470,267 ordinary shares, representing 0.50 per cent of the Company's total issued share capital.

The information contained in the notification is disclosed in accordance with the requirements of the EU Market Abuse Directive.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ian Robinson / Patricia Robinson

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Director / PCA

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Jaywing plc

b)

 

LEI

 

2138005USCN3ESKGRU20

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 5 pence each in Jaywing plc

Identification code

GB00BF5KDY46

b)

 

Nature of the transaction

 

Bed and ISA (involving both a Sale and Purchase of Ordinary Shares)

 

c)

 

Price(s) and volume(s)

Price

Volume

Sale

2.0p

470,267

Purchase

2.007p

470,267

d)

 

Aggregated information

- Aggregated volume

As above

- Price

e)

 

Date of the transaction

 

2 September 2024

f)

 

Place of the transaction

 

London Stock Exchange (AIM)

 

 

-Ends-

 For any further enquiries, please contact:

 For further information on the Company, please visit www.jaywing.com or contact:

 Jaywing plc

David Beck (Executive Chairman)

Christopher Hughes (CFO and COO)

T: +44 (0)333 370 6500

SPARK Advisory Partners Limited (Nominated and Financial Adviser)

Matt Davis / James Keeshan

T: +44 (0) 20 3368 3552

 

Turner Pope (Broker)

James Pope / Andy Thacker

T: +44 (0) 20 3657 0050

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGGLNZGGDZM
Date   Source Headline
13th Feb 20257:00 amRNSCancellation - Jaywing Plc
5th Feb 202510:39 amRNSResult of GM, Cancellation of Admission to Trading
21st Jan 20254:18 pmRNSCircular Amendment
14th Jan 20257:00 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSPublication of Circular and Notice of GM
23rd Dec 20243:02 pmRNSNotice of Requisition of General Meeting
19th Dec 20247:00 amRNSInterim Results
3rd Dec 20247:00 amRNSChange of Registered Office
7th Oct 20247:00 amRNSIncrease in Loan Facility
1st Oct 20247:00 amRNSTrading update and further funding
26th Sep 20242:42 pmRNSResult of AGM
4th Sep 20244:59 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSFinal Results
31st Jul 20241:58 pmRNSStatement regarding share price movement
21st Jun 202412:01 pmRNSUpdate on Loan Facility
28th May 20245:38 pmRNSIncrease in Loan Facility
13th May 20247:00 amRNSBoard, Trading Update, Strategic Review Conclusion
3rd Apr 202411:04 amRNSBoard Appointments
26th Mar 20241:57 pmRNSForm 8.3 - Jaywing PLC
18th Mar 20245:39 pmRNSForm 8.3 - Jaywing Plc
18th Mar 20245:31 pmRNSForm 8.3 - Jaywing plc
18th Mar 20242:02 pmRNSForm 8.3 - Jaywing plc
15th Mar 20244:45 pmRNSForm 8.3 - Jaywing Plc
15th Mar 20244:21 pmRNSForm 8.3 - Jaywing plc
14th Mar 20245:43 pmRNSForm 8.3 - Jaywing plc
14th Mar 20244:14 pmRNSForm 8.3 - Jaywing Plc
14th Mar 20241:53 pmRNSForm 8.3 - Jaywing PLC
7th Mar 20243:00 pmRNSForm 8
6th Mar 202411:09 amRNSForm 8.3 - Jaywing PLC
4th Mar 20243:56 pmRNSForm 8.3 - Jaywing plc
4th Mar 20249:25 amRNS2.9 Announcement
4th Mar 20247:00 amRNSTrading update, Loan Facility and Strategic Review
21st Dec 20237:00 amRNSHalf-year Report
20th Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
28th Sep 20234:28 pmRNSResult of AGM
7th Sep 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSGrant of Share Options
16th Feb 20237:00 amRNSTrading Update
14th Feb 202311:37 amRNSAIM Rule 17 Notification
5th Jan 20233:57 pmRNSHolding(s) in Company
1st Dec 20226:11 pmRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSHalf-year Report
11th Nov 202212:42 pmRNSHolding(s) in Company
8th Nov 20222:29 pmRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
29th Sep 20223:49 pmRNSResult of AGM
6th Sep 20222:01 pmRNSFinal Results
26th Aug 202211:59 amRNSAcquisition of Midisi Limited (replacement)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.